期刊文献+

糖化血红蛋白水平与不稳定性心绞痛择期冠状动脉介入术后对比剂肾病关系的研究 被引量:5

Relationship between glycated hemoglobin and contrast-induced nephropathy after selective percutaneous coronary intervention in patients with unstable angina pectoris
下载PDF
导出
摘要 目的探讨糖化血红蛋白(Hb A1c)与不稳定心绞痛(UA)择期冠状动脉介入治疗(PCI)患者术后发生对比剂肾病(CIN)的关系。方法选取2015年1月~2015年10月于北京安贞医院诊断UA并行择期PCI患者420例患者,根据Hb A1c水平分为实验组(Hb A1c≥6.5%,n=118)和对照组(Hb A1c〈6.5%,n=302)两组,比较两组患者术前及术后36 h血肌酐水平、内生肌酐清除率(Ccr)水平及CIN发生率,分析Hb A1c水平与不稳定性心绞痛患者择期PCI术后发生CIN的关系。结果实验组患者24.4%患者发生CIN,对照组患者0.67%发生CIN,实验组较对照组CIN发生率明显增高(P〈0.05)。二元Logistic回归分析显示Hb A1c水平≥6.5%是UA患者择期PCI术后发生CIN的独立危险因素(OR=5.711;95%CI:2.475~13.785,P=0.000)。结论不稳定心绞痛行择期冠状动脉介入治疗患者Hb A1c≥6.5%术后CIN发生率将明显升高。 Objective To discuss the relationship between glycated hemoglobin(Hb Alc) and contrastinduced nephropathy(CIN) after selective percutaneous coronary intervention(PCI) in patients with unstable angina pectoris(UAP). Methods UAP patients treated with selected PCI(n=420) were chosen from Jan. 2015 and Oct. 2015, and the divided, according to the level of Hb Alc, into test group(Hb A1c≥6.5%, n=118) and control group(Hb A1c6.5%, n=302). The levels of creatinine(Cr) and endogenous creatinine clearance rate(CCr), and incidence of CIN were compared between 2 groups before and 36 h after PCI. The relationship between Hb A1 c level and CIN after PCI was analyzed. Results The incidence of CIN was 24.4% in test group and 0.67% in control group(P0.05). The results of binary Logistic analysis showed that Hb A1 c level≥6.5% is the independent risk factor in UAP patients after selected PCI(OR=5.711; 95%CI: 2.475-13.785, P=0.000). Conclusion The incidence of CIN increases significantly in UPA patients with Hb A1 c level≥6.5% after selected PCI.
出处 《中国循证心血管医学杂志》 2016年第1期66-68,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 糖化血红蛋白 对比剂肾病 不稳定性心绞痛 经皮冠状动脉介入治疗 Glycated hemoglobin Contrast-induced nephropathy Unstable angina pectoris Percutaneous coronary intervention
  • 相关文献

参考文献15

  • 1Hocher B,Heunisch F,von Einem GF,et al. Urinary cGMP concentrations after exposure to radio-contrast media in patient at risk for contrast media induced nephropathy (CIN) predicts 90-day morbidity and mortality[J]. BMC Pharmaco Toxico,2013,14(Suppl 1):P29.
  • 2Moos SI,van Vemde DNH,Stoker J,et al. Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta- analysis[J]. Eur J Radiol,2013,82:e387-9.
  • 3王成钢,王春梅,高秀荣,方珊娟.糖化血红蛋白水平与急诊冠状动脉介入术后造影剂肾病关系研究[J].中华实用诊断与治疗杂志,2015,29(8):752-754. 被引量:3
  • 4裴源源,朱继红.急性心肌梗死后的急性肾损伤[J].中华急诊医学杂志,2015,24(7):704-708. 被引量:7
  • 5Braunwald E,Antman EM,Beasley JW,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non- ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)[J]. J Am Call Cardiol,2002,40(7): 1366-74.
  • 6Peter A,Fritsche A,Stefan N,et al. Diagnostic value of hemoglobin Alc for type 2 diabetes mellitus in a population at risk[J]. Exp Clin Endocrinol Diabetes,2011,119(4):234-7.
  • 7Marenzi G,Cabiati A,Milazzo V,et al. Contrast-induced nephropathy[J]. Intern Emerg Med,2012,7(Suppl 3):S181-3.
  • 8刘德平.2013版欧洲高血压指南解读[J].中国心血管杂志,2013,18(4):241-244. 被引量:30
  • 9梁峰,胡大一,沈珠军.2014美国糖尿病指南:糖尿病诊疗标准[J].中华临床医师杂志(电子版),2014,8(6):151-159. 被引量:196
  • 10郭改会,张沛然.高脂血症的诊断及治疗[J].中国临床医生杂志,2012,40(3):20-23. 被引量:38

二级参考文献51

  • 1张欣,王梅.造影剂肾病[J].中国医刊,2005,40(11):26-28. 被引量:4
  • 2Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 3钟历勇.应激对脂肪内分泌与神经内分泌的影响[J].中国行为医学科学,2007,16(3):283-284. 被引量:2
  • 4Darwish T. An evidence-based approach to minimise contrast-induced nepbropatby [ J ]. N Z Med J,2009,122 (1299) :39-41.
  • 5Alvarez-Sabin J, Molina CA, Ribo M, et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion [ J ]. Stroke,2004,35 ( 11 ) :2493 - 2498.
  • 6Ma YC, Li Z, Chen JH, et al. Modified Glomeruar Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease [J]. J Am Soc Nephrol,2006,17 (10) :2937-2944.
  • 7Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism [ J ]. Circulation, 2005, 117 (12) :1610-1619.
  • 8Ribo M, Molina C, Montaner J, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients [J]. Stroke,2005,36(8) :1705-1717.
  • 9Mancia G,Fagard R,Narkiewicz K,et al.2013 ESH/ESC Guidelines for the management of arterial hypertension.Blood Press,2013,22:193-278.
  • 10Rodrigues FB, Bruetto RG, Torres US, et al. Effect of kidney disease on acute coronary syndrome [J], Clin J Am Soc Nephrol, 2010, 5 (8) : 1530-1536.

共引文献276

同被引文献45

  • 1李玲,王晨霞.纤维蛋白原/白蛋白比值与心血管疾病关系研究进展[J].世界最新医学信息文摘,2020(34):121-123. 被引量:1
  • 2Kamijo-Ikemori A, Sugaya T, Yasuda T,et al. Clinical significance of urinary liver-type fatty acid-binding pro- tein in diabetic nephropathy of type 2 diabetic patients[J]. Diabetes Care, 2011,34 (3) : 691-696.
  • 3Zuo N,Suzuki Y,Sugaya T,et al. Protective effects of tubular liver-type fatty acidbinding protein against glomerular damage in murine IgA nephropathy[J]. Nephrol Dial Transplant, 2011,26 (7) : 2127 -2137.
  • 4Araki S,Haneda M,Koya D,et al. Predictive effects of urinary liver-type fatty acid-binding protein for deterio- rating renal function and incidence of cardiovascular dis- ease in type 2 diabetic patients without advanced nephropathy[J]. Diabetes Care, 2013,36(5) : 1248-1253.
  • 5Li WH,Li DY,Han F,etal. Impact of anemia on con- trast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions[J]. Int Urol Nephrol, 2013,45(4) : 1065"1070.
  • 6Ivanes F,Isorni MA,Halimi JM,et al. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty[J]. Arch Cardiovasc Dis,2014, 107(8-9) :424-432.
  • 7Mehran R,Aymong ED,Nikolsky E,et al. A simple risk score for prediction of contrast-induced nephropathy af- ter percutaneous coronary intervention[J]. J Am Coil Car- diol,2004,44(7) : 1393-1399.
  • 8Piskinpasa S,Ahun B,Akoglu H, et al. An uninvestigated risk factor for contrast-induced nephropathy in chronic kidney disease : Proteinuria[J]. Ren Fail, 2013,35 ( 1 ) : 62- 65.
  • 9庄丛明,刘映峰,江玲,缪绯.血清白介素6与胱抑素C在早期预测对比剂肾病中的意义[J].中国全科医学,2011,14(16):1801-1803. 被引量:6
  • 10郭改会,张沛然.高脂血症的诊断及治疗[J].中国临床医生杂志,2012,40(3):20-23. 被引量:38

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部